[1. Araghi M, Soerjomataram I, Jenkins M, Brierley J et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J Cancer 2019; 144(12): 2992–3000.]Search in Google Scholar
[2. Shin JK, Kim HC, Lee WY, Yun SH et al. High preoperative serum CA 19-9 levels can predict poor oncologic outcomes in colorectal cancer patients on propensity score analysis. Ann Surg Treat Res 2019; 96(3): 107–115.]Search in Google Scholar
[3. Labianca R, Beretta GD, Kildani B,Milesi L et al. Colon cancer. Crit Rev Oncol Hematol 2010; 74(2): 106–133.]Search in Google Scholar
[4. Brenner H, Kloor M, Pox CP. Colorectal cancer. The Lancet 2014; 383(9927): 1490–1502.]Search in Google Scholar
[5. Lopez G, Boggio F, Ferrero S, Fusco N, Del Gobbo A. Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma. IJMS 2018; 19(10): 3014.]Search in Google Scholar
[6. Nikolaou S, Qiu S, Fiorentino F, Rasheed S, Tekkis P, Kontovounisios C. Systematic review of blood diagnostic markers in colorectal cancer. Tech Coloproctol 2018; 22(7): 481–498.]Search in Google Scholar
[7. Dong H, Hu J, Wang L, Qi M et al. SOX4 is activated by C-MYC in prostate cancer. Med Oncol 2019; 36(11): 92.]Search in Google Scholar
[8. Moran JD, Kim HH, Li Z, Moreno CS. SOX4 regulates invasion of bladder cancer cells via repression of WNT5a. Int J Oncol 2019;55(2): 359–370.]Search in Google Scholar
[9. Moreno CS. SOX4: The unappreciated oncogene. Seminars in Cancer Biology 2019; 67: 57–64.]Search in Google Scholar
[10. Zhang J, Chai S, Ruan X. SOX4 Serves an Oncogenic Role in the Tumourigenesis of Human Breast Adenocarcinoma by Promoting Cell Proliferation, Migration and Inhibiting Apoptosis. Recent Pat Anticancer Drug Discov 2020; 15(1): 49-58.]Search in Google Scholar
[11. Hanieh H, Ahmed EA, Vishnubalaji R, Alajez NM. SOX4: Epigenetic regulation and role in tumorigenesis. Semin Cancer Biol 2020; 67: 91–104.]Search in Google Scholar
[12. SOX4 SRY-box transcription factor 4 [Homo sapiens (human)] – Gene –NC-BIn.d. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=6659 [citedJuly 6 2021].]Search in Google Scholar
[13. Wang B, Li Y, Tan F, Xiao Z. Increased expression of SOX4 is associated with colorectal cancer progression. Tumour Biol 2016; 37(7): 9131–9137.]Search in Google Scholar
[14. Vervoort SJ, van Boxtel R, Coffer PJ. The role of SRY – related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? Oncogene 2013; 32(29): 3397–3409.]Search in Google Scholar
[15. Liu Y, Zeng S, Jiang X, Lai D, Su Z. SOX4 inducestumourinvasion by targeting EMT-related pathway in prostate cancer. Tumour Biol 2017; 39(5): 1010428317694539.]Search in Google Scholar
[16. Wang L, Zhang J, Yang X, Chang YWY et al. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro. Prostate Cancer Prostatic Dis 2013; 16(4): 301–307.]Search in Google Scholar
[17. Tsai CN, Yu SC, Lee CW et al. SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo. Oncogene 2020; 39(24): 4695–4710.]Search in Google Scholar
[18. Lin C-M, Fang C-L, Hseu Y-C, Chen C-L et al. Clinical and Prognostic Implications of Transcription Factor SOX4 in Patients with Colon Cancer. PLoS One 2013; 8: e67128.]Search in Google Scholar
[19. MouT-Y, Zhang R-R, Wang Y-N. MiRNA –212 acts as atumour–suppressor in colorectal carcinoma through targeting SOX4. Eur Rev Med Pharmacol Sci 2019; 23(24): 10751–10760.]Search in Google Scholar
[20. Bao Z-Q, Zhang C-C, Xiao Y-Z, Zhou J-S, Tao Y-S, Chai D-M. Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma. J Huazhong Univ Sci Technolog Med Sci 2016; 36(2): 193-199.]Search in Google Scholar
[21. Jin M, Frankel WL. Lymph Node Metastasis in Colorectal Cancer. Surgical Oncology Clinics of North America 2018; 27(2): 401–412.]Search in Google Scholar
[22. Ruan H, Yang H, Wei H, Xiao W et al. Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition. Int J Oncol 2017; 51(1): 336–346.]Search in Google Scholar
[23. Zhang J, Xiao C, Feng Z, Gong Y et al. SOX4 promotes the growth and metastasis of breast cancer. Cancer Cell Int 2020; 20: 468.]Search in Google Scholar
[24. Yuan X, Wang S, Liu M, Lu Z et al. Histological and Pathological Assessment of miR-204 and SOX4 Levels in Gastric Cancer Patients. Biomed Res Int 2017; 6894675.]Search in Google Scholar
[25. Callender GG, McMasters KM. What does ulceration of a melanoma mean for prognosis? Adv Surg 2011; 45: 225–236.]Search in Google Scholar
[26. Micu BV, Vesa ŞC, Pop TR, Micu CM. Evaluation of prognostic factors for 5 year – survival after surgery for colorectal cancer. Ann Ital Chir 2020; 91: 41–48.]Search in Google Scholar
[27. Poornakala S, Prema NS. A study of morphological prognostic factors in colorectal cancer and survival analysis. Indian J Pathol Microbiol 2019; 62(1): 36–42. ]Search in Google Scholar
, 